Search Result
Results for "
PRRs
" in MedChemExpress (MCE) Product Catalog:
| Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-147089
-
|
|
Bacterial
Endogenous Metabolite
|
Infection
Inflammation/Immunology
|
|
PRRSV/CD163-IN-1 is a PRRSV/CD163 inhibitor. PRRSV/CD163-IN-1 can inhibit the interaction between the PRRSV glycoprotein (GP2a or GP4) and the CD163-SRCR5 domain. PRRSV/CD163-IN-1 can be used for the research of porcine reproductive and respiratory syndrome (PRRS) .
|
-
-
- HY-P3496
-
|
|
Pyroptosis
|
Inflammation/Immunology
|
|
Pep19-2.5 is an synthetic and antitoxin peptide, blocks the intracellular endotoxin signaling cascade. Pep19-2.5 inhibits signaling of lipopeptides (LP) and lipopolysaccharides (LPS) mediated by transmembrane and cytosolic pattern recognition receptors (PRRs). The signaling cascades lead to inflammation and cell pyroptosis .
|
-
-
- HY-RS11222
-
|
|
Small Interfering RNA (siRNA)
|
Others
|
|
PRR11 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
PRR11 Human Pre-designed siRNA Set A
PRR11 Human Pre-designed siRNA Set A
-
- HY-RS11223
-
|
|
Small Interfering RNA (siRNA)
|
Others
|
|
PRR12 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
PRR12 Human Pre-designed siRNA Set A
PRR12 Human Pre-designed siRNA Set A
-
- HY-RS11224
-
|
|
Small Interfering RNA (siRNA)
|
Others
|
|
PRR14 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
PRR14 Human Pre-designed siRNA Set A
PRR14 Human Pre-designed siRNA Set A
-
- HY-RS11225
-
|
|
Small Interfering RNA (siRNA)
|
Others
|
|
PRR15 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
PRR15 Human Pre-designed siRNA Set A
PRR15 Human Pre-designed siRNA Set A
-
- HY-RS11226
-
|
|
Small Interfering RNA (siRNA)
|
Others
|
|
PRR16 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
PRR16 Human Pre-designed siRNA Set A
PRR16 Human Pre-designed siRNA Set A
-
- HY-RS11227
-
|
|
Small Interfering RNA (siRNA)
|
Others
|
|
PRR20A Human Pre-designed siRNA Set A contains three designed siRNAs for PRR20A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
PRR20A Human Pre-designed siRNA Set A
PRR20A Human Pre-designed siRNA Set A
-
- HY-RS11228
-
|
|
Small Interfering RNA (siRNA)
|
Others
|
|
PRR21 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR21 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
PRR21 Human Pre-designed siRNA Set A
PRR21 Human Pre-designed siRNA Set A
-
- HY-RS11229
-
|
|
Small Interfering RNA (siRNA)
|
Others
|
|
PRR3 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
PRR3 Human Pre-designed siRNA Set A
PRR3 Human Pre-designed siRNA Set A
-
- HY-RS11230
-
|
|
Small Interfering RNA (siRNA)
|
Others
|
|
PRR35 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR35 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
PRR35 Human Pre-designed siRNA Set A
PRR35 Human Pre-designed siRNA Set A
-
- HY-RS11231
-
|
|
Small Interfering RNA (siRNA)
|
Others
|
|
PRR4 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
PRR4 Human Pre-designed siRNA Set A
PRR4 Human Pre-designed siRNA Set A
-
- HY-RS11232
-
|
|
Small Interfering RNA (siRNA)
|
Others
|
|
PRR5 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
PRR5 Human Pre-designed siRNA Set A
PRR5 Human Pre-designed siRNA Set A
-
- HY-RS11233
-
|
|
Small Interfering RNA (siRNA)
|
Others
|
|
PRR7 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
PRR7 Human Pre-designed siRNA Set A
PRR7 Human Pre-designed siRNA Set A
-
- HY-RS11234
-
|
|
Small Interfering RNA (siRNA)
|
Others
|
|
PRR9 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
PRR9 Human Pre-designed siRNA Set A
PRR9 Human Pre-designed siRNA Set A
-
- HY-P10396
-
|
|
Bacterial
|
Infection
Inflammation/Immunology
|
|
Elf18 is the bacterial N-terminal fragment of Elongation Factor Thermus (EF-Tu). Elf18 is recognized by pattern recognition receptors (PRRs) as a pathogen-associated molecular pattern (PAMP), and thus induces immune response in Arabidopsis .
|
-
-
- HY-138646
-
|
Poly(dA:dT) sodium
|
Cyclic GMP-AMP Synthase
AIM2
|
Infection
Cancer
|
|
Polydeoxyadenylic-thymidylic acid (Poly(dA:dT)) sodium is a synthetic DNA polymer. Poly(dA:dT) sodium can be used to determine the activity of bound and free ribonucleic acid polymerase. Poly(dA:dT) sodium is recognized by multiple PRRs (cytosolic DNA sensors (CDS), including cGAS, AIM2, DAI, DDX41, IFI16, and LRRFIP1), and triggers the production of type I interferons. Poly(dA:dT) sodium can be used for the research of cancer and virus infection .
|
-
-
- HY-159751
-
|
|
Toll-like Receptor (TLR)
|
Inflammation/Immunology
|
|
HS101 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .
|
-
-
- HY-159743
-
|
|
Toll-like Receptor (TLR)
|
Inflammation/Immunology
|
|
M101 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .
|
-
-
- HY-159748
-
|
|
Toll-like Receptor (TLR)
|
Inflammation/Immunology
|
|
M402 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .
|
-
-
- HY-152157
-
|
|
HIV
|
Infection
|
|
HIV-1 inhibitor-52 is a potent broad-spectrum HIV-1 activity inhibitor with EC50s of 1.6 nM-6.4 nM for WT HIV-1, HIV-1 V370A, HIV-1 ΔV370, HIV-1 V362I/V370A, HIV-1 T332S/V362I/prR41G, HIV-1 A326T/V362I/V370A, HIV-1 R361K/V362I/L363M .
|
-
| Cat. No. |
Product Name |
Target |
Research Area |
-
- HY-P3496
-
|
|
Pyroptosis
|
Inflammation/Immunology
|
|
Pep19-2.5 is an synthetic and antitoxin peptide, blocks the intracellular endotoxin signaling cascade. Pep19-2.5 inhibits signaling of lipopeptides (LP) and lipopolysaccharides (LPS) mediated by transmembrane and cytosolic pattern recognition receptors (PRRs). The signaling cascades lead to inflammation and cell pyroptosis .
|
-
- HY-P10396
-
|
|
Bacterial
|
Infection
Inflammation/Immunology
|
|
Elf18 is the bacterial N-terminal fragment of Elongation Factor Thermus (EF-Tu). Elf18 is recognized by pattern recognition receptors (PRRs) as a pathogen-associated molecular pattern (PAMP), and thus induces immune response in Arabidopsis .
|
| Cat. No. |
Product Name |
Category |
Target |
Chemical Structure |
| Cat. No. |
Product Name |
|
Classification |
-
- HY-RS11222
-
|
|
|
siRNAs
Pre-designed siRNA Sets
|
|
PRR11 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS11223
-
|
|
|
siRNAs
Pre-designed siRNA Sets
|
|
PRR12 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS11224
-
|
|
|
siRNAs
Pre-designed siRNA Sets
|
|
PRR14 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS11225
-
|
|
|
siRNAs
Pre-designed siRNA Sets
|
|
PRR15 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS11226
-
|
|
|
siRNAs
Pre-designed siRNA Sets
|
|
PRR16 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS11227
-
|
|
|
siRNAs
Pre-designed siRNA Sets
|
|
PRR20A Human Pre-designed siRNA Set A contains three designed siRNAs for PRR20A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS11228
-
|
|
|
siRNAs
Pre-designed siRNA Sets
|
|
PRR21 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR21 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS11229
-
|
|
|
siRNAs
Pre-designed siRNA Sets
|
|
PRR3 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS11230
-
|
|
|
siRNAs
Pre-designed siRNA Sets
|
|
PRR35 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR35 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS11231
-
|
|
|
siRNAs
Pre-designed siRNA Sets
|
|
PRR4 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS11232
-
|
|
|
siRNAs
Pre-designed siRNA Sets
|
|
PRR5 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS11233
-
|
|
|
siRNAs
Pre-designed siRNA Sets
|
|
PRR7 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS11234
-
|
|
|
siRNAs
Pre-designed siRNA Sets
|
|
PRR9 Human Pre-designed siRNA Set A contains three designed siRNAs for PRR9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-159751
-
|
|
|
Adjuvant
|
|
HS101 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .
|
-
- HY-159752
-
|
|
|
Adjuvant
|
|
HS103 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .
|
-
- HY-159753
-
|
|
|
Adjuvant
|
|
HS105 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .
|
-
- HY-159754
-
|
|
|
Adjuvant
|
|
HS201 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .
|
-
- HY-159746
-
|
|
|
Adjuvant
|
|
HS801 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .
|
-
- HY-159743
-
|
|
|
Adjuvant
|
|
M101 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .
|
-
- HY-159744
-
|
|
|
Adjuvant
|
|
M103 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .
|
-
- HY-159745
-
|
|
|
Adjuvant
|
|
M107 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .
|
-
- HY-159747
-
|
|
|
Adjuvant
|
|
M401 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .
|
-
- HY-159748
-
|
|
|
Adjuvant
|
|
M402 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .
|
-
- HY-159749
-
|
|
|
Adjuvant
|
|
M902 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .
|
-
- HY-159750
-
|
|
|
Adjuvant
|
|
M903 is a vaccine adjuvant and a key component in vaccines. Adjuvants can be divided into immunostimulants and delivery systems. Adjuvants can not only enhance the intensity and durability of immune responses, but also affect the type of immune responses. On the one hand, immunostimulants promote the production of antigen signals and co-stimulatory signals by targeting Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), leading to the maturation and activation of antigen presenting cells (APCs), thereby enhancing adaptive immune responses; on the other hand, delivery systems are carrier materials that promote antigen delivery by prolonging the bioavailability of loaded antigens and targeting antigens to lymph nodes or APCs. Several common adjuvants include: saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants .
|
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent:
